The final results validate conclusions drawn by Bagli et al. [one], who performed a study that included 10 patients diagnosed with CRAO who been given HBOT. Together with acquiring twenty sessions of HBOT, oral acetazolamide and topical beta-blockers were being administered to the patients at the earliest achievable time.Youn et al. [54] highlighte